Wellington Management Group LLP Kymera Therapeutics, Inc. Transaction History

Wellington Management Group LLP

$551 Billion
Q1 2024

A detailed history of Wellington Management Group LLP transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 4,293,697 shares of KYMR stock, worth $130 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

4,293,697

Holding current value

$130 Million

% of portfolio

0.03%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$22.9 - $43.57 $98.3 Million - $187 Million	4,293,697 New	4,293,697 $173 Million
Q4 2023 Feb 12, 2024	BUY	$10.97 - $26.84 $52.8 Million - $129 Million	4,815,558 New	4,815,558 $123 Million
Q3 2023 Nov 14, 2023	BUY	$13.9 - $23.88 $8,979 - $15,426	646 Added 0.01%	4,823,329 $67 Million
Q2 2023 Aug 14, 2023	BUY	$22.4 - $34.92 $11.9 Million - $18.6 Million	531,665 Added 12.39%	4,822,683 $111 Million
Q1 2023 May 12, 2023	SELL	$24.84 - $38.75 $7.45 Million - $11.6 Million	-300,071 Reduced 6.54%	4,291,018 $127 Million

Q4 2022 Feb 13, 2023	BUY	$19.57 - $30.92 $23.1 Million - $36.5 Million	1,180,703 Added 34.62%	4,591,089 $115 Million
Q3 2022 Nov 14, 2022	SELL	$20.91 - $34.27 $34 Million - $55.7 Million	-1,624,554 Reduced 32.27%	3,410,386 $74.2 Million
Q2 2022 Aug 15, 2022	BUY	$14.13 - $42.55 $25.6 Million - $77 Million	1,809,191 Added 56.09%	5,034,940 $99.1 Million
Q1 2022 May 16, 2022	BUY	$35.3 - $64.68 $18.7 Million - $34.3 Million	530,935 Added 19.7%	3,225,749 $137 Million
Q4 2021 Feb 11, 2022	BUY	$49.91 - $65.56 $11.3 Million - $14.9 Million	226,879 Added 9.19%	2,694,814 $171 Million
Q3 2021 Nov 15, 2021	BUY	$47.8 - $66.66 $78.4 Million - $109 Million	1,639,994 Added 198.08%	2,467,935 $145 Million
Q2 2021 Aug 16, 2021	BUY	$31.08 - $51.95 $4.93 Million - $8.24 Million	158,648 Added 23.7%	827,941 $40.2 Million
Q1 2021 May 17, 2021	SELL	$35.64 - $85.46 $36.4 Million - $87.3 Million	-1,021,286 Reduced 60.41%	669,293 $26 Million
Q4 2020 Feb 12, 2021	SELL	$28.07 - $87.83 $2.07 Million - $6.46 Million	-73,605 Reduced 4.17%	1,690,579 $104 Million
Q3 2020 Nov 16, 2020	BUY	$26.1 - $33.28 $46 Million - $58.7 Million	1,764,184 New	1,764,184 $55.8 Million

Others Institutions Holding KYMR

# of Institutions

164

Shares Held

63.1M

Call Options Held

39.7K

Put Options Held

9.7K

View Full List

About Kymera Therapeutics, Inc.

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $1.65B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

More about KYMR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP Kymera Therapeutics, Inc. Transaction History